Chronic conditions like cancer and endometriosis remain difficult to diagnose accurately due to the limitations of current imaging tools. Cancer is the most misdiagnosed of the 'big three' conditions, and 75% of endometriosis patients receive an incorrect diagnosis and are forced to undergo diagnostic surgery. While MRI and PET-CT often miss small findings, ultrasound is highly operator-dependent and inconsistent, leaving a critical gap in the early and reliable detection of disease.
Revealan™, our robotic ultrasound imaging platform, seamlessly integrates with any off-the-shelf ultrasound device to enable operator-agnostic, automated, AI-enabled, high-resolution 3D imaging. The robotic scan output is a series of standardized medical images with a density 10 times higher than that of an MRI. With Revealan™, we allow early detection and reliable follow-ups of small findings. Revealan™ is optimizing ultrasound for better patient outcomes.
